Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Ultragenyx Pharmaceutical Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Ultragenyx Pharmaceutical Inc. May 14, 202689.4%
-
10x Genomics Inc. June 3, 202586.0%
-
Ultragenyx Pharmaceutical Inc. June 7, 202392.9%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 22, 2026 | 10x Genomics Inc. | Open-market sale | −292 | $78.20 | $22,834 |
| Sep 22, 2026 | 10x Genomics Inc. | Open-market sale | −614 | $79.51 | $48,819 |
| Sep 22, 2026 | 10x Genomics Inc. | Open-market sale | −1,325 | $80.82 | $107,087 |
| Sep 22, 2026 | 10x Genomics Inc. | Open-market sale | −2,270 | $81.67 | $185,391 |
| Sep 22, 2026 | 10x Genomics Inc. | Open-market sale | −1,222 | $82.28 | $100,546 |
| Aug 24, 2026 | 10x Genomics Inc. | Open-market sale | −561 | $62.73 | $35,192 |
| Aug 24, 2026 | 10x Genomics Inc. | Open-market sale | −1,646 | $63.97 | $105,295 |
| Jun 16, 2026 | 10x Genomics Inc. | Open-market sale | −5,359 | $32.59 | $174,650 |
| Jun 16, 2026 | 10x Genomics Inc. | Open-market sale | −364 | $33.27 | $12,110 |
| Jun 4, 2026 | 10x Genomics Inc. | Grant or award | +8,829 | — | — |
| May 18, 2026 | Ultragenyx Pharmaceutical Inc. | Open-market sale | −5,740 | $25.12 | $144,189 |
| May 14, 2026 | Ultragenyx Pharmaceutical Inc. | Grant or award | +7,751 | — | — |
| Jun 3, 2025 | 10x Genomics Inc. | Grant or award | +15,357 | — | — |
| May 15, 2025 | Ultragenyx Pharmaceutical Inc. | Grant or award | +5,740 | — | — |
| Jun 18, 2024 | Ultragenyx Pharmaceutical Inc. | Grant or award | +5,345 | — | — |
Questions about Shehnaaz Suliman
What boards is Shehnaaz Suliman on?
Shehnaaz Suliman sits on the boards of 10x Genomics Inc. and Ultragenyx Pharmaceutical Inc.
How long has Shehnaaz Suliman served on boards?
Our records show at least 7 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.